Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2)

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Journal of Virology

• Publication date

  1985-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/jvi.55.2.347-351.1985PMID 2410629PMCID PMC254939
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.

  1984cited by this paper
• Early events in the infection of human B lymphocytes by Epstein-Barr virus: the internalization process.

  1984cited by this paper
• Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.

  1984cited by this paper
• Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody.

  1984cited by this paper
• Mouse Ia antigens are receptors for lactate dehydrogenase virus

  1984cited by this paper
• Infection of B lymphocytes by a human herpesvirus, Epstein-Barr virus, is blocked by calmodulin antagonists.

  1984cited by this paper
• Amino acid sequence similarity between rabies virus glycoprotein and snake venom curaremimetic neurotoxins.

  1984cited by this paper
• Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

  1984influential reference
• Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 Fragments for Factors B and H, complement receptors , and bovine conglutinin

  1983cited by this paper
• Replication of Epstein–Barr virus in human epithelial cells infected in vitro

  1983cited by this paper
• B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.

  1983cited by this paper
• Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.

  1983cited by this paper
• Generation and characterization of monoclonal antibodies reactive with human B lymphocytes.

  1983cited by this paper
• Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody

  1983influential reference
• The role of C3 fragments in endocytosis and extracellular cytotoxic reactions by polymorphonuclear leukocytes.

  1982cited by this paper
• Is the acetylcholine receptor a rabies virus receptor?

  1982cited by this paper
• Receptors for the complement C3d component and the Epstein-Barr virus are quantitatively coexpressed on a series of B-cell lines and their derived somatic cell hybrids.

  1982cited by this paper
• Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.

  1982cited by this paper
• Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences

  1981cited by this paper
• Characterization of a human B cell-specific antigen (B2) distinct from B1.

  1981cited by this paper
• Induction of complement receptor expression in cell lines derived from human undifferentiated lymphomas. II. Characterization of the induced complement receptors and demonstration of the simultaneous induction of EBV receptor.

  1981cited by this paper
• Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody.

  1981cited by this paper
• Isolation of Epstein Barr-virus and studies of its neutralization by human IgG and complement.

  1981influential reference
• A simplified two-dimensional electrophoretic technique.

  1981cited by this paper
• T suppressor (TG) lymphocytes fluctuate in parallel with changes in the clinical course of patients with multiple sclerosis.

  1979cited by this paper
• Translocation of a hydrocarbon fluorescent probe between Epstein-Barr virus and lymphoid cells: an assay for early events in viral infection.

  1978cited by this paper
• Relationship between epstein‐barr virus (EBV)‐production and the loss of the ebv receptor/complement receptor complex in a series of sublines derived from the same original burkitt's lymphoma

  1978cited by this paper
• Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies.

  1978cited by this paper
• Membrane receptor stripping confirms the association between ebv receptors and complement receptors on the surface of human b lymphoma lines

  1977cited by this paper
• Surface markers on human B‐ and T‐lymphocytes. IX. Two‐color immunofluorescence studies on the association between EBV receptors and complement receptors on the surface of lymphoid cell lines

  1976cited by this paper
• Surface Markers on Human B and T Lymphocytes

  1976cited by this paper
• Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoic cell lines and in the blood of patients with infectious mononucleosis.

  1975cited by this paper
• Surface Markers on Human B and T Lymphocytes

  1974cited by this paper
• SURFACE MARKERS ON HUMAN B AND T LYMPHOCYTES

  1973cited by this paper
• Induction of Cellular DNA Synthesis in Human Leucocytes by Epstein–Barr Virus

  1971cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• The gut microbiota in cancer immunity and immunotherapy

  2025cites this paper
• Roadside Dust as a Silent Threat: Toxic Elements Contamination and Multi-Pathway Exposure Risks in Rangpur City of Bangladesh

  2025cites this paper
• Adoptive T-cell therapy for virus-associated diseases

  2025cites this paper
• Assessing the fitness of Epstein-Barr virus following its reactivation

  2025cites this paper
• The Functional Interaction Between Epstein–Barr Virus and MYC in the Pathogenesis of Burkitt Lymphoma

  2024cites this paper
• Structural biology of complement receptors

  2023cites this paper
• MYC directly transactivates CR2/CD21, the receptor of the Epstein–Barr virus, enhancing the viral infection of Burkitt lymphoma cells

  2023cites this paper
• MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, and enhances the viral infection of Burkitt lymphoma cells

  2022cites this paper
• Tree Shrew Is a Suitable Animal Model for the Study of Epstein Barr Virus

  2022cites this paper
• Systematic analysis of Epstein-Barr virus genes and their individual contribution to virus production and composition

  2021cites this paper
• Targeting Host Cellular Factors as a Strategy of Therapeutic Intervention for Herpesvirus Infections

  2021cites this paper
• Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals

  2020cites this paper
• Effects of Epstein-Barr Virus Infection on CD19+ B Lymphocytes in Patients with Immunorelated Pancytopenia

  2020cites this paper
• CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells

  2020cites this paper
• Transnasal endoscopic resection of Epstein-Barr virus–associated cavernous sinus tumour

  2020cites this paper
• From conifers to cognition: Microbes, brain and behavior

  2020cites this paper
• Effects of copper mining on heavy metal contamination in a rice agrosystem in the Xiaojiang River Basin, southwest China

  2019cites this paper
• Antitumor activity of cyclin‐dependent kinase inhibitor alsterpaullone in Epstein‐Barr virus‐associated lymphoproliferative disorders

  2019cites this paper
• Engineering extracellular vesicles as novel treatment options: exploiting herpesviral immunity in CLL

  2019cites this paper
• EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers

  2018cites this paper
• Human herpes virus antibody levels in helminth treated and placebo controlled multiple sclerosis patients

  2018cites this paper
• A causation-based method developed for an integrated risk assessment of heavy metals in soil.

  2018cites this paper
• Expressed in the Central Nervous System and Complement-Regulatory Protein Highly CSMD1 Is a Novel Multiple Domain

  2017cites this paper
• Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL).

  2017cites this paper
• A comparative review of viral entry and attachment during large and giant dsDNA virus infections

  2017cites this paper
• Structural and functional studies of the cell cycle regulator RGC-32

  2017cites this paper
• Complement Evasion Strategies of Viruses: An Overview

  2017cites this paper
• Vital Role of Complement Receptor 2 ( CR 2 / CD 21 ) Along With Other Proteins in the Pathogenesis of Systemic Lupus Erythematosus

  2017cites this paper
• Unraveling the role of membrane microdomains during microbial infections

  2017cites this paper
• Epstein-Barr Virus and Cytomegalovirus

  2016cites this paper
• The Structure-Function Relationships of Complement Receptor Type 2 (CR2; CD21).

  2016cites this paper
• Immunotherapy against cancer-related viruses

  2016cites this paper
• Targeting the Ca2 + Sensor STIM1 by Exosomal Transfer of Ebv-miR-BART13-3p is Associated with Sjögren's Syndrome

  2016influential citation
• Ebv-miR-BART13-3p is Associated with Sjögren's Syndrome

  2016cites this paper
• The Anatomy of a Career in Science

  2016cites this paper
• Molecular insights into host gene regulation by Epstein-Barr virus nuclear antigen EBNA3C

  2016cites this paper
• Development of MHC class II-restricted TCR gene therapy for Epstein Barr virus associated malignancies

  2016cites this paper
• Development and application of a quantitative PCR assay to study the pathogenicity of equine herpesvirus 5

  2016cites this paper
• To elucidate the Epstein-Barr virus replisome

  2016cites this paper
• The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment

  2015cites this paper
• Innate immunity in progressive multiple sclerosis

  2015cites this paper
• EBV Persistence--Introducing the Virus.

  2015influential citation
• Healthy rabbits are susceptible to Epstein-Barr virus infection and infected cells proliferate in immunosuppressed animals

  2015cites this paper
• [History of resaerch on Epstein-Barr virus--target cells of infection, and disease].

  2014cites this paper
• Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies

  2014cites this paper
• Human Lymphoblastoid Cell Lines in Pharmacogenomics

  2014cites this paper
• Epstein-Barr Virus Type 2 Latently Infects T Cells, Inducing an Atypical Activation Characterized by Expression of Lymphotactic Cytokines

  2014influential citation
• Role of latent membrane protein 1 in chronic active Epstein–Barr virus infection-derived T/NK-cell proliferation

  2014cites this paper
• Production of human monoclonal antibodies by the epstein-barr virus method.

  2014cites this paper
• How viruses use the immune system to promote infection of polarized cells

  2014cites this paper
• Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells

  2014cites this paper
• Epstein Barr virus entry; kissing and conjugation.

  2014cites this paper
• Epstein-Barr virus infection and replication in stratified epithelial cells

  2014cites this paper
• Mutational analysis and protein interactions ofEpstein-Barr virus protein Zta, with reference to ZtaRh, a homologue from Cercopithecine herpesvirus-15

  2013cites this paper
• KEGG orthology-based annotation of the predicted proteome of Acropora digitifera: ZoophyteBase - an open access and searchable database of a coral genome

  2013cites this paper
• Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor.

  2013cites this paper
• Lymphoma in Other Diseases

  2013cites this paper
• Fluorosomes: Fluorescent Virus-Like Nanoparticles that Represent a Convenient Tool to Visualize Receptor-Ligand Interactions

  2013cites this paper
• Entry of herpesviruses into cells: the enigma variations.

  2013cites this paper
• Potential Therapeutic Molecular Targets for Nasopharyngeal Carcinoma

  2012cites this paper
• Inhibition of Epstein-Barr Virus Infection by Lactoferrin

  2012cites this paper
• The biology of EBV infection in human epithelial cells.

  2012cites this paper
• Epstein-Barr Virus Infection of Naïve B Cells In Vitro Frequently Selects Clones with Mutated Immunoglobulin Genotypes: Implications for Virus Biology

  2012cites this paper
• Investigating the role of Epstein-Barr virus in the pathogenesis of NK and T cell lymphoproliferations

  2011cites this paper
• [Receptor virus-cell interactions as an initial stage of infection].

  2011cites this paper
• Control of the EBV growth transformation programme : the importance of the Bamhi W repeats

  2011cites this paper
• Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes.

  2011cites this paper
• hu-PBL-SCID mice : an in vivo model of Epstein-Barr virus-dependent Iymphoproliferative disease

  2011cites this paper
• Epstein-Barr Virus Infection of Polarized Epithelial Cells via the Basolateral Surface by Memory B Cell-Mediated Transfer Infection

  2011cites this paper
• EBV-gp350 Confers B-Cell Tropism to Tailored Exosomes and Is a Neo-Antigen in Normal and Malignant B Cells—A New Option for the Treatment of B-CLL

  2011influential citation
• receptor type-1 for invasion of human erythrocytes uses a key functional site in complement

  2011cites this paper
• Mapping regions of Epstein-Barr virus (EBV) glycoprotein B (gB) important for fusion function with gH/gL.

  2011cites this paper
• Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations

  2011cites this paper
• Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.

  2011cites this paper
• Haptoglobin polymorphism and infection.

  2010cites this paper
• The role of the alternative pathway of the complement system in the development of dense deposit disease

  2010cites this paper
• Delineation of the complement receptor type 2-C3d complex by site-directed mutagenesis and molecular docking.

  2010cites this paper
• Inhibition du cycle lytique du Virus Epstein-Barr par ARN interférence

  2010cites this paper
• Biophysical Investigations of Complement Receptor 2 (CD21 and CR2)-Ligand Interactions Reveal Amino Acid Contacts Unique to Each Receptor-Ligand Pair*

  2010cites this paper
• Learning from the Viral Journey: How to Enter Cells and How to Overcome Intracellular Barriers to Reach the Nucleus

  2009cites this paper
• The haptoglobin phenotype is associated with the Epstein-Barr virus antibody titer

  2009cites this paper
• Early Events Associated with Infection of Epstein-Barr Virus Infection of Primary B-Cells

  2009cites this paper
• Mammalian Host Defenses: Innate and Adaptive Immunity

  2009cites this paper
• Epstein-Barr Virus in Lymphoproliferative Processes: An Update for the Diagnostic Pathologist

  2009cites this paper
• Stable expression of EBV-gp350 on the surface of NC37 cells confers natural killer (NK)-cell susceptibility or resistance, depending on the assay used to assess NK-mediated function.

  2009cites this paper
• Die Rolle des Epstein-Barr Virus in der Lymphompathogenese

  2009cites this paper
• ROLE OF LATENT EBV GENES IN THE INDUCTION OF GENOMIC INSTABILITY IN BURKITT'S LYMPHOMA

  2009cites this paper
• Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay.

  2009cites this paper
• Functional Analysis of Glycoprotein L (gL) from Rhesus Lymphocryptovirus in Epstein-Barr Virus-Mediated Cell Fusion Indicates a Direct Role of gL in gB-Induced Membrane Fusion

  2009cites this paper
• Mapping of the C3d Ligand Binding Site on Complement Receptor 2 (CR2/CD21) Using Nuclear Magnetic Resonance and Chemical Shift Analysis*

  2009cites this paper
• Virus Entry into Animal Cells

  2008cites this paper
• and Mouse CR1 and CR2 Comparative Functional Evolution of Human

  2008cites this paper
• Gamma herpesviruses: Pathogenesis of infection and cell signaling

  2008cites this paper
• Laser-capture microdissection of oropharyngeal epithelium indicates restriction of Epstein-Barr virus receptor/CD21 mRNA to tonsil epithelial cells.

  2008influential citation
• Entry of herpesviruses into mammalian cells

  2008cites this paper
• Molecular Basis of the Interaction between Complement Receptor Type 2 (CR2/CD21) and Epstein-Barr Virus Glycoprotein gp350

  2008cites this paper
• Comparative Functional Evolution of Human and Mouse CR1 and CR212

  2008cites this paper
• Quantifying EBV-specific CD8? T cell immunity in patients with post transplant lymph proliferative disease (PTLD) and other EBV-driven malignancies.

  2008cites this paper
• Posttransplant Epstein‐Barr Virus‐Associated Myogenic Tumors: Case Report and Review of the Literature

  2007cites this paper
• Epstein-Barr Virus Entry

  2007cites this paper